Cargando…

Investigation of the causal etiology in a patient with T-B+NK+ immunodeficiency

Newborn screening for severe combined immunodeficiency (SCID) has not only accelerated diagnosis and improved treatment for affected infants, but also led to identification of novel genes required for human T cell development. A male proband had SCID newborn screening showing very low T cell recepto...

Descripción completa

Detalles Bibliográficos
Autores principales: Sertori, Robert, Lin, Jian-Xin, Martinez, Esteban, Rana, Sadhna, Sharo, Andrew, Kazemian, Majid, Sunderam, Uma, Andrake, Mark, Shinton, Susan, Truong, Billy, Dunbrack, Roland M., Liu, Chengyu, Srinivasan, Rajgopol, Brenner, Steven E., Seroogy, Christine M., Puck, Jennifer M., Leonard, Warren J., Wiest, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372720/
https://www.ncbi.nlm.nih.gov/pubmed/35967429
http://dx.doi.org/10.3389/fimmu.2022.928252
_version_ 1784767449300729856
author Sertori, Robert
Lin, Jian-Xin
Martinez, Esteban
Rana, Sadhna
Sharo, Andrew
Kazemian, Majid
Sunderam, Uma
Andrake, Mark
Shinton, Susan
Truong, Billy
Dunbrack, Roland M.
Liu, Chengyu
Srinivasan, Rajgopol
Brenner, Steven E.
Seroogy, Christine M.
Puck, Jennifer M.
Leonard, Warren J.
Wiest, David L.
author_facet Sertori, Robert
Lin, Jian-Xin
Martinez, Esteban
Rana, Sadhna
Sharo, Andrew
Kazemian, Majid
Sunderam, Uma
Andrake, Mark
Shinton, Susan
Truong, Billy
Dunbrack, Roland M.
Liu, Chengyu
Srinivasan, Rajgopol
Brenner, Steven E.
Seroogy, Christine M.
Puck, Jennifer M.
Leonard, Warren J.
Wiest, David L.
author_sort Sertori, Robert
collection PubMed
description Newborn screening for severe combined immunodeficiency (SCID) has not only accelerated diagnosis and improved treatment for affected infants, but also led to identification of novel genes required for human T cell development. A male proband had SCID newborn screening showing very low T cell receptor excision circles (TRECs), a biomarker for thymic output of nascent T cells. He had persistent profound T lymphopenia, but normal numbers of B and natural killer (NK) cells. Despite an allogeneic hematopoietic stem cell transplant from his brother, he failed to develop normal T cells. Targeted resequencing excluded known SCID genes; however, whole exome sequencing (WES) of the proband and parents revealed a maternally inherited X-linked missense mutation in MED14 (MED14(V763A)), a component of the mediator complex. Morpholino (MO)-mediated loss of MED14 function attenuated T cell development in zebrafish. Moreover, this arrest was rescued by ectopic expression of cDNA encoding the wild type human MED14 ortholog, but not by MED14(V763A) , suggesting that the variant impaired MED14 function. Modeling of the equivalent mutation in mouse (Med14(V769A)) did not disrupt T cell development at baseline. However, repopulation of peripheral T cells upon competitive bone marrow transplantation was compromised, consistent with the incomplete T cell reconstitution experienced by the proband upon transplantation with bone marrow from his healthy male sibling, who was found to have the same MED14(V763A) variant. Suspecting that the variable phenotypic expression between the siblings was influenced by further mutation(s), we sought to identify genetic variants present only in the affected proband. Indeed, WES revealed a mutation in the L1 cell adhesion molecule (L1CAM(Q498H)); however, introducing that mutation in vivo in mice did not disrupt T cell development. Consequently, immunodeficiency in the proband may depend upon additional, unidentified gene variants.
format Online
Article
Text
id pubmed-9372720
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93727202022-08-13 Investigation of the causal etiology in a patient with T-B+NK+ immunodeficiency Sertori, Robert Lin, Jian-Xin Martinez, Esteban Rana, Sadhna Sharo, Andrew Kazemian, Majid Sunderam, Uma Andrake, Mark Shinton, Susan Truong, Billy Dunbrack, Roland M. Liu, Chengyu Srinivasan, Rajgopol Brenner, Steven E. Seroogy, Christine M. Puck, Jennifer M. Leonard, Warren J. Wiest, David L. Front Immunol Immunology Newborn screening for severe combined immunodeficiency (SCID) has not only accelerated diagnosis and improved treatment for affected infants, but also led to identification of novel genes required for human T cell development. A male proband had SCID newborn screening showing very low T cell receptor excision circles (TRECs), a biomarker for thymic output of nascent T cells. He had persistent profound T lymphopenia, but normal numbers of B and natural killer (NK) cells. Despite an allogeneic hematopoietic stem cell transplant from his brother, he failed to develop normal T cells. Targeted resequencing excluded known SCID genes; however, whole exome sequencing (WES) of the proband and parents revealed a maternally inherited X-linked missense mutation in MED14 (MED14(V763A)), a component of the mediator complex. Morpholino (MO)-mediated loss of MED14 function attenuated T cell development in zebrafish. Moreover, this arrest was rescued by ectopic expression of cDNA encoding the wild type human MED14 ortholog, but not by MED14(V763A) , suggesting that the variant impaired MED14 function. Modeling of the equivalent mutation in mouse (Med14(V769A)) did not disrupt T cell development at baseline. However, repopulation of peripheral T cells upon competitive bone marrow transplantation was compromised, consistent with the incomplete T cell reconstitution experienced by the proband upon transplantation with bone marrow from his healthy male sibling, who was found to have the same MED14(V763A) variant. Suspecting that the variable phenotypic expression between the siblings was influenced by further mutation(s), we sought to identify genetic variants present only in the affected proband. Indeed, WES revealed a mutation in the L1 cell adhesion molecule (L1CAM(Q498H)); however, introducing that mutation in vivo in mice did not disrupt T cell development. Consequently, immunodeficiency in the proband may depend upon additional, unidentified gene variants. Frontiers Media S.A. 2022-07-29 /pmc/articles/PMC9372720/ /pubmed/35967429 http://dx.doi.org/10.3389/fimmu.2022.928252 Text en Copyright © 2022 Sertori, Lin, Martinez, Rana, Sharo, Kazemian, Sunderam, Andrake, Shinton, Truong, Dunbrack, Liu, Srinivasan, Brenner, Seroogy, Puck, Leonard and Wiest https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Sertori, Robert
Lin, Jian-Xin
Martinez, Esteban
Rana, Sadhna
Sharo, Andrew
Kazemian, Majid
Sunderam, Uma
Andrake, Mark
Shinton, Susan
Truong, Billy
Dunbrack, Roland M.
Liu, Chengyu
Srinivasan, Rajgopol
Brenner, Steven E.
Seroogy, Christine M.
Puck, Jennifer M.
Leonard, Warren J.
Wiest, David L.
Investigation of the causal etiology in a patient with T-B+NK+ immunodeficiency
title Investigation of the causal etiology in a patient with T-B+NK+ immunodeficiency
title_full Investigation of the causal etiology in a patient with T-B+NK+ immunodeficiency
title_fullStr Investigation of the causal etiology in a patient with T-B+NK+ immunodeficiency
title_full_unstemmed Investigation of the causal etiology in a patient with T-B+NK+ immunodeficiency
title_short Investigation of the causal etiology in a patient with T-B+NK+ immunodeficiency
title_sort investigation of the causal etiology in a patient with t-b+nk+ immunodeficiency
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372720/
https://www.ncbi.nlm.nih.gov/pubmed/35967429
http://dx.doi.org/10.3389/fimmu.2022.928252
work_keys_str_mv AT sertorirobert investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT linjianxin investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT martinezesteban investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT ranasadhna investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT sharoandrew investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT kazemianmajid investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT sunderamuma investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT andrakemark investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT shintonsusan investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT truongbilly investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT dunbrackrolandm investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT liuchengyu investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT srinivasanrajgopol investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT brennerstevene investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT seroogychristinem investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT puckjenniferm investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT leonardwarrenj investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency
AT wiestdavidl investigationofthecausaletiologyinapatientwithtbnkimmunodeficiency